FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904238545> ?p ?o ?g. }

• W2904238545 endingPage "405" @default.
• W2904238545 startingPage "395" @default.
• W2904238545 abstract "Multiple real-world studies have reported potential cost savings associated with second-generation antipsychotic long-acting injectable therapies (SGA-LAIs), including once monthly paliperidone palmitate (PP1M). Yet, only about 12% of Medicaid patients with schizophrenia initiate SGA-LAIs, with poor adherence contributing to frequent relapse among patients on oral atypical antipsychotics (OAAs). The objective of this study was to project the economic impact when an incremental proportion of non-adherent patients with a recent relapse switched from OAAs to PP1M.A 12 month decision-tree model was developed from a Medicaid payers' perspective. The target population was non-adherent OAA patients with a recent relapse. At equal adherence, risk of relapse was equal between PP1M and OAAs, and OAA patients remained non-adherent until treatment switch. Outcomes included number of relapses, relapse costs and pharmacy costs.Based on a hypothetical health plan of 1 million members, 3037 schizophrenia patients were non-adherent on OAAs with a recent relapse. Compared to continuing OAAs, switching 5% of patients (n = 152) to PP1M resulted in net schizophrenia-related cost savings of $674,975 at a plan level, $4445 per patient switched per year and $0.0562 per member per month, with a total of 92 avoided relapses over 12 months. Total annual plan level schizophrenia-related costs were $114.1 M when all patients switched to PP1M before any subsequent relapse (n = 3037), $123.4 M when patients switched to PP1M after a first subsequent relapse (n = 2631), and $127.6 M when all patients continued OAAs. Switching all patients to PP1M before any subsequent relapse averted 917 relapses, at a lower cost per patient switched ($37,559) compared to switching after a first subsequent relapse ($45,089) or continuing OAAs ($42,005).Over 12 months, pharmacy costs associated with switching patients from OAAs to PP1M were offset by reduced relapse rates and schizophrenia-related healthcare expenditures, with earlier use of PP1M projected to generate greater cost savings." @default.
• W2904238545 created "2018-12-22" @default.
• W2904238545 creator A5019269759 @default.
• W2904238545 creator A5024491186 @default.
• W2904238545 creator A5033890213 @default.
• W2904238545 creator A5049847939 @default.
• W2904238545 creator A5057168807 @default.
• W2904238545 creator A5062980852 @default.
• W2904238545 creator A5090831117 @default.
• W2904238545 creator A5091710566 @default.
• W2904238545 date "2019-01-03" @default.
• W2904238545 modified "2023-10-17" @default.
• W2904238545 title "The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia" @default.
• W2904238545 cites W1151536748 @default.
• W2904238545 cites W1512307838 @default.
• W2904238545 cites W1686753980 @default.
• W2904238545 cites W1753194806 @default.
• W2904238545 cites W1969060266 @default.
• W2904238545 cites W1983223296 @default.
• W2904238545 cites W1986011584 @default.
• W2904238545 cites W1989794259 @default.
• W2904238545 cites W2009652756 @default.
• W2904238545 cites W2012696366 @default.
• W2904238545 cites W2050417509 @default.
• W2904238545 cites W2052968398 @default.
• W2904238545 cites W2057464084 @default.
• W2904238545 cites W2058417208 @default.
• W2904238545 cites W2061481707 @default.
• W2904238545 cites W2065542563 @default.
• W2904238545 cites W2068596607 @default.
• W2904238545 cites W2069024810 @default.
• W2904238545 cites W2075029547 @default.
• W2904238545 cites W2087684793 @default.
• W2904238545 cites W2099226437 @default.
• W2904238545 cites W2103616822 @default.
• W2904238545 cites W2105052641 @default.
• W2904238545 cites W2107842992 @default.
• W2904238545 cites W2110370987 @default.
• W2904238545 cites W2134675761 @default.
• W2904238545 cites W2136402295 @default.
• W2904238545 cites W2137175526 @default.
• W2904238545 cites W2138418531 @default.
• W2904238545 cites W2143855802 @default.
• W2904238545 cites W2151707703 @default.
• W2904238545 cites W2165397843 @default.
• W2904238545 cites W2252889185 @default.
• W2904238545 cites W2320970266 @default.
• W2904238545 cites W2326858746 @default.
• W2904238545 cites W2333903607 @default.
• W2904238545 cites W2344245029 @default.
• W2904238545 cites W2470402736 @default.
• W2904238545 cites W2512163677 @default.
• W2904238545 cites W2553460568 @default.
• W2904238545 cites W2563907022 @default.
• W2904238545 cites W2588682411 @default.
• W2904238545 cites W2603711939 @default.
• W2904238545 cites W2621159104 @default.
• W2904238545 cites W2696309480 @default.
• W2904238545 cites W2737271551 @default.
• W2904238545 cites W2747351937 @default.
• W2904238545 cites W2754382591 @default.
• W2904238545 cites W2766647939 @default.
• W2904238545 cites W2781554206 @default.
• W2904238545 cites W2801704870 @default.
• W2904238545 cites W2803457478 @default.
• W2904238545 cites W2884219199 @default.
• W2904238545 cites W2916950229 @default.
• W2904238545 doi "https://doi.org/10.1080/03007995.2018.1558195" @default.
• W2904238545 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30526125" @default.
• W2904238545 hasPublicationYear "2019" @default.
• W2904238545 type Work @default.
• W2904238545 sameAs 2904238545 @default.
• W2904238545 citedByCount "5" @default.
• W2904238545 countsByYear W29042385452019 @default.
• W2904238545 countsByYear W29042385452020 @default.
• W2904238545 countsByYear W29042385452023 @default.
• W2904238545 crossrefType "journal-article" @default.
• W2904238545 hasAuthorship W2904238545A5019269759 @default.
• W2904238545 hasAuthorship W2904238545A5024491186 @default.
• W2904238545 hasAuthorship W2904238545A5033890213 @default.
• W2904238545 hasAuthorship W2904238545A5049847939 @default.
• W2904238545 hasAuthorship W2904238545A5057168807 @default.
• W2904238545 hasAuthorship W2904238545A5062980852 @default.
• W2904238545 hasAuthorship W2904238545A5090831117 @default.
• W2904238545 hasAuthorship W2904238545A5091710566 @default.
• W2904238545 hasConcept C118552586 @default.
• W2904238545 hasConcept C126322002 @default.
• W2904238545 hasConcept C160735492 @default.
• W2904238545 hasConcept C162324750 @default.
• W2904238545 hasConcept C2776412080 @default.
• W2904238545 hasConcept C2776534028 @default.
• W2904238545 hasConcept C2777126507 @default.
• W2904238545 hasConcept C2780057945 @default.
• W2904238545 hasConcept C2780494398 @default.
• W2904238545 hasConcept C2908647359 @default.
• W2904238545 hasConcept C2908997079 @default.
• W2904238545 hasConcept C50522688 @default.
• W2904238545 hasConcept C71924100 @default.

• next